Browse > Article
http://dx.doi.org/10.5392/JKCA.2012.12.07.273

Occurrence and Prognosis for the Thrombosis in the Drug-Eluting Stents and Bare-Metal Stents  

Kim, In-Soo (동신대학교 방사선학과)
Choi, Nam-Gil (동신대학교 방사선학과)
Jang, Seong-Joo (동신대학교 방사선학과)
Han, Jae-Bok (동신대학교 방사선학과)
Jang, Young-Ill (광양보건대학교 방사선과)
Publication Information
The Journal of the Korea Contents Association / v.12, no.7, 2012 , pp. 273-283 More about this Journal
Abstract
Drug-eluting stents (DES) have significantly reduced in-stent restenosis, compared to bare-metal stents (BMS). However, there remains concern for the increased risk of stent thrombosis (ST) associated with DES. The present study sought to evaluate the incidence, clinical characteristics and outcome of ST in patients with acute myocardial infarction (MI) during a 1-year follow-up. 80 patients who developed ST were divided into 2 groups according to stent type: group I (DES-ST, n = 57 ) and group II (BMS-ST, n = 23 ). There were no differences between group I and II in the overall incidence of ST (2.7% vs. 4.3%, p=0.064) and in the incidence of each type of ST: acute ST (8.8% vs. 2.3%), subacute ST (50.9% vs. 60.9%), late ST (19.3% vs. 8.7%), and very late ST (21.1% vs. 17.4%) (p=0.605). Predictors of 1-year mortality were the occurrence of ST (OR 8.12, 95% CI 2.83-23.61, p<0.001), left ventricular ejection fraction<40% (OR 6.41, 95% CI 2.42-16.96, p<0.001), and age${\geq}$75 years (OR 4.98, 95% CI 1.95-12.74, p=0.001).
Keywords
Drug-eluting stents; Stent thrombosis; Percutaneous Coronary Intervention;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 US Food and Drug Administration Public Health Web Notification, "FDA advises physicians of adverse events associated with Cordis Cypher coronary stents," T03-T71, 2003.
2 I. Iakovou, T. Schmidt, and E. Bonizzoni, "Incidence, predictors, and outcome of thrombosis after successful implantation of drugeluting stents," JAMA, Vol.293, pp.2126-2130, 2005.   DOI   ScienceOn
3 J. Daemen, P. Wenaweser, and K. Tsuchida, "Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study," Lancet, Vol.369, pp.667-678, 2007.   DOI   ScienceOn
4 J. Oyabu, Y. Ueda, N. Ogasawara, K. Okada, A. Hirayama, and K. Kodama, "Angioscopic evaluation of neointima coverage: sirolimus drugeluting stent versus bare metal stent," Am Heart J, Vol.152, pp.1168-1174, 2006.   DOI   ScienceOn
5 H. W. Park, M. H. Jeong, and O. Y. Park, "The long-term clinical effects of heparin coated coronary stent," Korean Circ J, Vol.32, pp.773-780, 2002.   DOI
6 W. Kim, M. H. Jeong, and K.S. Cha, "The effect of anti-oxidants (carvedilol and probucol) loaded stents in a porcine coronary restenosis model," Circ J, Vol.69, pp.101-106, 2005.   DOI   ScienceOn
7 W. Kim, M. H. Jeong, and Y. J. Hong, "The long-term clinical results of a platelet glycoprotein IIb/IIIa receptor blocker (Abciximab:$ReoPro^{(R)}$) coated stent in patients with acute myocardial infarction," Korean Circ J, Vol.34, pp.1063-1069, 2004.   DOI
8 Y. J. Hong, M. H. Jeong, and W. Kim "Effect of abciximab-coated stent on in-stent intimal hyperplasia in human coronary arteries," Am J Cardiol, Vol.94, pp.1050-1054, 2004.   DOI   ScienceOn
9 O. Y. Park, M. H. Jeong, and J. H. Kim, "The inhibitory effects of a platelet glycoprotein IIb/IIIa receptor blocker-coated stent on neointima formation and inflammatory response in porcine coronary stent restenosis," Korean Circ J, Vol.33, pp.439-445, 2003.   DOI
10 E. Schampaert, J. W. Moses, and J. Schofer "Sirolimus-eluting stents at two years: a pooled analysis of SIRIUS, E-SIRIUS, and C-SIRIUS with emphasis on late revascularizations and stent thromboses," Am J Cardiol, Vol.98, pp.36-41, 2006.   DOI   ScienceOn
11 D. E. Cutlip, S. Windecker, and R. Mehran, "Clinical end points in coronary stent trials: a case for standardized definitions," Circulation, Vol.115, No.17, pp.2344-2345, 2007.   DOI   ScienceOn
12 J. H. Moon, M. H. Jeong, and I. S. Kim, "The Frequency, Treatment and Clinical Outcomes of Stent Thrombosi after Use of TAXUSTM Stent," Korean Circ J, Vol.37, pp.641-646, 2007.   DOI   ScienceOn
13 C. L. Grines, R. O. Bonow, and D. E. Jr Casey, "Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians," Catheter Cardiovasc Interv, Vol.69, pp.334-340, 2007.   DOI   ScienceOn
14 S. Y. Lim and M. H. Jeong, "Is heparin-coated stent effective in patients with acute myocardial infarction?," Korean Circ J, Vol.34, pp.537-539, 2004.   DOI
15 W. Kim, M. H. Jeong, and K. H. Kim, "The clinical results of a platelet glycoprotein IIb/IIIa receptor blocker (abciximab-ReoPro) -coated stent in acute myocardial infarction," J Am Coll Cardiol, Vol.47, pp.933-938, 2006.   DOI   ScienceOn
16 A. Farb and A. B. Boam, "Stent thrombosis redux: the FDA perspective," N Engl J Med, Vol.356, pp.984-987, 2007.   DOI   ScienceOn
17 G. De Luca, G. Carbone, A. Maione, and G. Gregorio, "In-stent thrombosis after discontinuation of antiplatelet therapy 2 years after DES implantation: a case report," Int J Cardiol, Vol.116, pp.399-400, 2007.   DOI   ScienceOn
18 R. Artang and R. S. Dieter, "Analysis of 36 reported cases of late thrombosis in drug-eluting stents placed in coronary arteries," Am J Cardiol, Vol.99, pp.1039-1043, 2007.   DOI   ScienceOn
19 F. Burzotta, E. Romagnoli, and A. Manzoli, "The Outcome of PCI for stent-ThrombosIs MultIcentre Study (OPTIMIST): rationale and design of a multicenter registry," Am Heart J Vol.153, p.377, 2007.
20 J. Schofer, M. Schluter, and A. H. Gershlick, "Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS)," Lancet, Vol.362, pp.1093-1099, 2003.   DOI   ScienceOn
21 S. J. Park, Y. H. Kim, and B. K. Lee, "Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation," J Am Coll Cardiol, Vol.45, pp.351-356, 2005.   DOI   ScienceOn
22 S. Park, G. R. Hong, H. S. Seo, and S. J. Tahk, "Stent thrombosis after successful drug-eluting stent implantation," Korean Circ J, Vol.35, pp.163-171, 2005.   DOI
23 S. Y. Lim, E. H. Bae, and M. H. Jeong "The effect of oral administration of alpha lipoic acid and alpha lipoic acid coated stent in porcine in-stent restenosis model," Korean Circ J, Vol.36, pp.495-502, 2006.   DOI
24 P. W. Serruys, B. H. Strauss, H. M. van Beusekom, and W. J. van der Giessen, "Stenting of coronary arteries: has a modern Pandora' box been opened?," J Am Coll Cardiol, Vol.17, pp.143B-154B, 1991.
25 I. S. Kim, J. B. Han, S. J. Jang, and Y. I. Jang, "The Study on the Independent Predictive Factor of Restenosis afterPercutaneous Coronary Intervention used Drug-Eluting Stent : Case on MDCT Calcium-Scoring Implementation Patient," 방사선기술학회지, Vol.33, No.1, pp.37-44, 2010.
26 A. Jeremias, B. Sylvia, and J. Bridges, "Stent thrombosis after successful sirolimus-eluting stent implantation," Circulation, Vol.109, pp.1930-1932, 2004.   DOI   ScienceOn
27 D. W. Park and S. W. Park, "Stent thrombosis in the era of the drugeluting stent," Korean Circ J, Vol.35, pp.791-794, 2005.   DOI
28 J. Daemen, H. M. Garcia-Garcia, and N. Kukreja, "The long-term value of sirolimusand paclitaxel-eluting stents over bare metal stents in patients with diabetes mellitus," Eur Heart J, Vol.28, pp.26-32, 2007.
29 S. G. Ellis, A. Colombo, and E. Grube, "Incidence, timing, and correlates of stent thrombosis with the polymeric paclitaxel drug-eluting stent: a TAXUS II, IV, V, and VI meta-analysis of 3,445 patients followed for up to 3 years," J Am Coll Cardiol, Vol.49, pp.1043-1051, 2007.   DOI   ScienceOn
30 R. Moreno, C. Fernandez, and R. Hernandez, "Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies," J Am Coll Cardiol, Vol.45, pp.954-959, 2005.   DOI   ScienceOn
31 J. W. Moses, M. B. Leon, and J. J. Popma, "Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery," N Engl J Med, Vol.349, pp.1315-1323, 2003.   DOI   ScienceOn
32 J. W. Moses, M. B. Leon, and J. J. Popma, "Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery," N Engl J Med, Vol.349, pp.1315-1323, 2003.   DOI   ScienceOn
33 J. E. Sousa, M. A. Costa, and A. G. Sousa, "Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries," Circulation, Vol.107, pp.381-383, 2003.   DOI   ScienceOn
34 G. W. Stone, S. G. Ellis, and D. A. Cox, "One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent," Circulation, Vol.109, pp.1942-1947, 2004.   DOI   ScienceOn
35 M. C. Morice, P. W. Serruys, and J. E. Sousa, "A randomized comparison of a sirolimuseluting stent with a standard stent for coronary revascularization," N Engl J Med, Vol.346, pp.1773-1780, 2002.   DOI   ScienceOn
36 G. W. Stone, S. G. Ellis, and D. A. Cox, "A polymer-based, paclitaxelelutin stent in patients with coronary artery disease," N Engl J Med, Vol.350, pp.221-231, 2004.   DOI   ScienceOn
37 A. Colombo, J. Drzewiecki, and A. Banning, "Randomized study to assess the effectiveness of slow- and moderate-release polymerbased paclitaxel-eluting stents for coronary artery lesions," Circulation, Vol.108, pp.788-794, 2003.   DOI   ScienceOn
38 E. Schampaert, E. A. Cohen, and M. Schluter, "The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS)," J Am Coll Cardiol, Vol.43, pp.1110-1115, 2004.   DOI   ScienceOn
39 J. E. Sousa, M. A. Costa, and A. Abizaid, "Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study," Circulation, Vol.103, pp.192-195, 2001.   DOI   ScienceOn